PTC launches Codebeamer 3.0 to speed up product development, boost sustainability and ensure quality and compliance with full traceability and smarter tools.
PTC Therapeutics said on Friday the European Commission will remove its inherited progressive muscle-wasting disorder from the region after an advisory panel reaffirmed a negative opinion of the drug in January.
PTC basically offers end-to-end software solutions for managing the product lifecycle across diverse industries. Their flagship platforms are Windchill, Codebeamer, ServiceMax, and Creo, which overall help with operational efficiency and quality improvements. PTC is also quickly transitioning toward cloud-native SaaS tools. Good examples of this are their Onshape and Arena new offerings.
PTC will unveil Windchill AI, Codebeamer AI and ServiceMax AI at Hannover Messe 2025, promising innovation and fostering digital transformation.
PTC Therapeutics is poised for a potential turnaround with key FDA reviews in 2025 for vatiquinone and sepiapterin, despite past revenue declines. The company maintains a strong cash position of over $2 billion, providing a buffer as it awaits regulatory approvals to boost revenue. PTC's diversified pipeline, including vatiquinone for Friedreich's ataxia, could significantly enhance revenue if approved, targeting a $2.8 billion market.
PTC Inc. (PTC) reported earnings 30 days ago. What's next for the stock?
Sometimes, the headline numbers don't tell the whole story. That's definitely the case with industrial software company PTC (PTC 0.05%) and workflow technology company Trimble (TRMB 1.11%).
Shares in industrial software company PTC (PTC -9.84%) were lower by 8.8% in the week to Thursday afternoon. The move comes after a poorly received first-quarter 2025 earnings released on Wednesday.
PTC's Q1 performance is driven by strength in its subscription-based business model and innovative product portfolio against a volatile sales backdrop.
PTC Inc. (NASDAQ:PTC ) Q1 2025 Earnings Conference Call February 5, 2025 5:00 PM ET Company Participants Matt Shimao - Head of Investor Relations Neil Barua - President and Chief Executive Officer Kristian Talvitie - Chief Financial Officer Conference Call Participants Jay Vleeschhouwer - Griffin Securities, Inc. Jason Celino - KeyBanc Capital Markets Inc. Ken Wong - Oppenheimer & Co. Inc. Siti Panigrahi - Mizuho Securities Co., Ltd. Stephen Tusa - JPMorgan Chase & Co. Arsenije Matovic - Wolfe Research, LLC Nay Soe Naing - Berenberg Saket Kalia - Barclays Operator Good afternoon, ladies and gentlemen.
The headline numbers for PTC Inc. (PTC) give insight into how the company performed in the quarter ended December 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
PTC Inc. (PTC) came out with quarterly earnings of $1.10 per share, beating the Zacks Consensus Estimate of $0.91 per share. This compares to earnings of $1.11 per share a year ago.